Jaxwest15: Drug study: Efficacy of Docetaxel and Paclitaxel in a patient-derived mammary carcinoma xenograft model in female NOD scid gamma (NSG) immunodeficient mice (2013)
Yang Y
Purpose of study:
To determine the therapeutic efficacy of two standard of care drugs (Docetaxel and Paclitaxel) in a patient-derived mammary carcinoma xenograft (PDX) model in female NOD scid gamma (NSG) immunodeficient mice.
To determine the therapeutic efficacy of two standard of care drugs (Docetaxel and Paclitaxel) in a patient-derived mammary carcinoma xenograft (PDX) model in female NOD scid gamma (NSG) immunodeficient mice.
Jaxwest15 downloads
Click on "Download" link or button below, to see the available downloads for this project.
Click on "Download" link or button below, to see the available downloads for this project.
| Investigators |
Yan Yang The Jackson Laboratory, Bar Harbor, ME |
| Contact | Yan Yang yan.yang@jax.org
|
| Affiliated Center | JAX In Vivo Services |
| One-strain study | |
| MPD identifiers | Jaxwest15 MPD:499 |
| No updates/corrections. Initial release date: 01/2014. | |
|
Click above to copy-paste the entire citation for this MPD web page. |
• Protocol and experimental design
• Study involves NSG females Full strain name: NOD.Cg-Prkdcscid_Il2rgtm1Wjl/SzJ
• Additional information
• Docetaxel (Wikipedia)
• Paclitaxel (Wikipedia)
• PDX triple negative mammary carcinoma: TM00089 (BR0602F)
By posting these data, JAX In Vivo Pharmacology Services contributes to community research resources and fulfills an agreement with clients to make normative data public.